RELMAPIRAZIN
UNII Q3UQB8PQ6H

Substance Identification & Data

This profile provides standardized clinical and technical data for Relmapirazin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q3UQB8PQ6H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1313706-17-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q3UQB8PQ6H

CAS Registry Number

1313706-17-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RELMAPIRAZIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C12H16N6O8

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XHNJXRDGTITISI-QWWZWVQMSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C152179

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

53389120

Unique identification number in the NCBI database of chemical substances.

INN ID

10626

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-85

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

OC(=O)[C@@H](CO)NC(=O)c1c(N)nc(C(N[C@@H](C(O)=O)CO)=O)c(N)n1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Relmapirazin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.